Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    0.00 (0.00%)
Bid:
4,800.00
Ask:
7,200.00
Spread: 2,400.00 (50.00%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Acquisition

10 Sep 2010 07:00

RNS Number : 4595S
Diploma PLC
10 September 2010
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

10 September 2010

 

 

DIPLOMA PLC

 

DIPLOMA ACQUIRES AN OEM SEALS BUSINESS IN THE UNITED STATES AND A HEALTHCARE BUSINESS IN AUSTRALIA

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is pleased to announce the acquisition of 100% of All Seals Inc ("All Seals") for a maximum consideration of £7.8m (US$11.9m), before expenses. On 30 July 2010, Diploma PLC also completed the acquisition of 80% of Big Green Surgical Company Pty Limited ("BGS") for a maximum consideration of £1.4m (A$2.4m), before expenses.

 

All Seals Inc

 

All Seals is a well established supplier of O rings and custom moulded seals to Industrial OEM customers across a range of specialist applications in aerospace, medical, agriculture and general manufacturing industries. All Seals employs 22 staff and operates from a leased facility in Santa Ana, California in the United States.

 

All Seals will join the Hercules Fluid Power Group ("HFPG"), Diploma's North American Seals Group, alongside HFPG's other OEM seal business, RT Dygert. All Seals and RT Dygert will be complementary businesses within HFPG as All Seals sells ca. 75% of its product in California and the South Western states of the US, while RT Dygert is concentrated in the Mid-West.

 

At the time of acquisition, All Seals was owned by Mr J Barnett who will remain as an Executive until 31 December 2010, and thereafter be available as a consultant to the business.

 

Unaudited revenues of All Seals in the year ended 31 December 2009, when industrial markets were particularly weak, were US$7.8m (£5.1m). In the first eight months of 2010, revenues have rebounded strongly and are ca. 30% ahead of the prior comparable period.

 

The initial cash consideration for All Seals will be US$10.5m (£6.9m), which will be met from the Group's existing cash resources. This may be subject to minor adjustment based on the net assets at completion. Further deferred consideration up to an aggregate maximum of US$1.4m (£0.9m) may be payable in 2011, depending primarily on the operating profit out-turn of the business in the year ending 31 December 2010.

 

Big Green Surgical Company Pty Limited

 

BGS is a specialised distributor of electrosurgery consumables and equipment supplied to both public and private hospitals in Australia and New Zealand. The business is a smaller, more narrowly focused version of the Group's existing AMT Electrosurgery business in Canada and shares a number of common suppliers. BGS employs 6 staff and operates from a small leased facility in Newcastle, close to Sydney in New South Wales, Australia.

 

At the time of acquisition, BGS was jointly owned by Mr & Mrs A Bennett and Mr Bennett will remain in place as Managing Director following the acquisition for a minimum period of three years. BGS will report directly into the management team of Diploma's Canadian Healthcare businesses.

 

In the year ended 30 June 2010, BGS reported unaudited revenues of A$3.4m (£2.0m). The initial consideration paid for 80% of the share capital was A$2.4m (£1.4m). The outstanding 20% of shares will be retained by the Managing Director for three years and be subject to put/call options, based on an agreed multiple of operating profit.

 

The Board expects both acquisitions to be immediately earnings enhancing for the Group.

 

Bruce Thompson, Chief Executive of Diploma PLC said:

 

"The acquisition of All Seals is an important addition to our developing OEM Seals business in North America. The BGS acquisition, although relatively small, is strategically important in opening up new geographic opportunities for our established Healthcare business."

 

 

 

 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

 

 

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 825 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 16% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £290m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQKKCDBABKDKCK
Date   Source Headline
17th Jan 20184:30 pmRNSResult of AGM
17th Jan 20187:00 amRNSTrading Statement
28th Dec 20174:13 pmRNSDirector/PDMR Shareholding
12th Dec 20173:18 pmRNSHolding(s) in Company
8th Dec 20173:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
20th Nov 20177:00 amRNSFinal Results
25th Oct 201710:00 amRNSHolding(s) in Company
25th Oct 20179:50 amRNSHolding(s) in Company
29th Sep 20174:00 pmRNSDirector Declaration
27th Sep 20177:00 amRNSDirectorate Change
26th Sep 201712:41 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSResult of Statutory Audit Tender
30th Aug 20177:00 amRNSTrading Update
17th Aug 20173:29 pmRNSHolding(s) in Company
16th Jun 20179:00 amRNSHolding(s) in Company
14th Jun 20174:05 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
20th Apr 20177:00 amRNSAcquisition
18th Apr 20179:44 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSTrading Update
23rd Mar 20173:05 pmRNSDirector/PDMR Shareholding
13th Mar 20172:08 pmRNSHolding(s) in Company
16th Feb 20175:10 pmRNSHolding(s) in Company
14th Feb 201711:57 amRNSHolding(s) in Company
1st Feb 20177:00 amRNSCapital Markets Day
18th Jan 20174:34 pmRNSResult of AGM
18th Jan 20177:00 amRNSTrading Statement
9th Jan 201711:30 amRNSHolding(s) in Company
5th Jan 201711:26 amRNSHolding(s) in Company
22nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20163:35 pmRNSDirector Declaration
8th Dec 20163:00 pmRNSAnnual Financial Report & Notice of AGM
30th Nov 20164:00 pmRNSDirector/PDMR Shareholding
21st Nov 20167:00 amRNSFinal Results
19th Oct 20162:57 pmRNSHolding(s) in Company
31st Aug 20167:00 amRNSTrading Statement
15th Aug 20164:00 pmRNSHolding(s) in Company
13th Jun 20164:00 pmRNSNotice of Adoption of FRS 101
16th May 20167:00 amRNSHalf Year Announcement
8th Apr 201611:01 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSTrading Update
9th Mar 20167:00 amRNSAcquisition
17th Feb 201610:08 amRNSHolding(s) in Company
21st Jan 20161:46 pmRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSDirectorate Change
20th Jan 20164:58 pmRNSResult of AGM
20th Jan 20167:00 amRNSFirst Quarter Trading Update
17th Dec 201510:00 amRNSDirector/PDMR Shareholding
11th Dec 201511:38 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.